Related Experiment Videos
Acylthioxanthenes: agents which selectively reduce decerebrate rigidity in the cat
Journal of Medicinal Chemistry
|June 1, 1980
Summary
Researchers synthesized novel thioxanthene derivatives to reduce rigidity in cats. (Z)-2-propionyl-9-[3-(dimethylamino)propylidene]thioxanthene showed the best therapeutic potential with minimal sedation.
Area of Science:
- Medicinal Chemistry
- Neuropharmacology
Background:
- Decerebrate rigidity in cats is a model for studying muscle tone.
- Thioxanthene derivatives have shown potential in modulating neurological pathways.
Purpose of the Study:
- To synthesize and evaluate novel 2-acylthioxanthene-delta 9 (gamma)-propylamine derivatives.
- To identify compounds with potent muscle rigidity-reducing effects and minimal sedative side effects.
Main Methods:
- Synthesis of a series of 2-acylthioxanthene-delta 9 (gamma)-propylamine compounds.
- In vivo evaluation of anti-rigidity effects in decerebrate cats.
- Assessment of sedative properties at effective anti-rigidity doses.
- Isomer separation and characterization using 1H NMR spectroscopy with an europium shift reagent.
Main Results:
- Several compounds demonstrated the ability to reduce intercollicular decerebrate rigidity.
- (Z)-2-propionyl-9-[3-(dimethylamino)propylidene]thioxanthene exhibited the most favorable therapeutic index, showing significant rigidity reduction with minimal sedation.
- 1H NMR spectroscopy effectively differentiated between Z and E isomers.
Conclusions:
- The synthesized thioxanthene derivatives show promise as potential therapeutic agents for conditions involving muscle rigidity.
- (Z)-2-propionyl-9-[3-(dimethylamino)propylidene]thioxanthene is a lead compound warranting further investigation.
- NMR spectroscopy is a valuable tool for isomer characterization in this chemical series.